🇺🇸 FDA
Patent

US 8227446

Oligodeoxynucleotide and its use to induce an immune response

granted A61KA61K2039/55561A61K31/7088

Quick answer

US patent 8227446 (Oligodeoxynucleotide and its use to induce an immune response) held by The United States of America as Represented by the Secretary of the Department of Health and Human Services expires Mon Jul 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America as Represented by the Secretary of the Department of Health and Human Services
Grant date
Tue Jul 24 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
27
CPC classes
A61K, A61K2039/55561, A61K31/7088, A61K39/008, A61K39/39